Tempus AI has surged ~75% since August, but current valuations (~15x EV/forward revenue) are unsustainable for its hybrid ...
Zacks Investment Research on MSN
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
Tempus AI, Inc. TEM continues to strengthen its position in precision medicine through strategic acquisitions. In a move to expand its digital pathology capabilities, the company announced the $81.25 ...
AZoLifeSciences on MSN
The Resolution Revolution: How Electron Microscopy Is Transforming Structural Studies
Cryo-electron microscopy and tomography are transforming structural biology, offering unprecedented insights into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback